Details for France Supplementary Protection Certificate: 13C0022
✉ Email this page to a colleague
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1506211 | 13C0022 | France | PRODUCT NAME: DAPAGLIFLOZINE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/12/795/001 20121112 | ⤷ Try a Trial |